chromosome 9p deletion syndrome

MeSH: C538024ORPHA: 2611121 Treatment Available

Overview

Human disease

Available Treatments (1)

DrugFormStatusCountriesLead Time
Growth hormone (somatropin)
Orphan Cold Chain
Subcutaneous injection, 5mg, 12mg cartridgesFDA Approved814d

Clinical Presentation

Signs and symptoms associated with chromosome 9p deletion syndrome, sourced from HPO and Orphanet clinical annotations.

High palateTrigonocephalyBrachycephalyMalar flatteningHypertelorismLong philtrumMicrognathiaLow-set earsAnteverted naresWebbed neckShort neckBlepharophimosisIntellectual disabilityGlobal developmental delayThin nailLow posterior hairlineDepressed nasal bridgeWide intermamillary distanceAbnormal dermatoglyphicsMicrotiaProximal placement of thumbAbnormal antihelix morphologyAnotiaCryptorchidismHypospadiasAmbiguous genitaliaNarrow mouthAbnormality of the dentitionMicrocephalyEpicanthusStrabismusThick eyebrowUpslanted palpebral fissureNystagmusSynophrysSeizureHypotoniaHypertoniaLimitation of joint mobilityAbnormality of the tarsal bonesHighly arched eyebrowScoliosisShort noseUreteropelvic junction obstructionCleft palateAtresia of the external auditory canalChoanal atresiaDownslanted palpebral fissuresMicrophthalmiaAbnormal rib morphologyCongenital diaphragmatic herniaAbnormality of the vertebral columnPostaxial hand polydactylyAgenesis of corpus callosumCalvarial skull defectBilateral single transverse palmar creasesAbnormal cardiovascular system morphologyHernia

Classification & Codes

MeSH Code

C538024

Orphanet Code

ORPHA:261112
chromosome 9p deletion syndrome
MeSHC538024
OrphanetORPHA:261112
Treatments1 drug(s)
Symptoms on record58 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
chromosome 9p deletion syndrome | OrphanDrug